Source: Annual Congress 2002 - Lung disposition clinical outcomes: effect of delivery device
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Koivumäki, M. Vahteristo (Espoo, Kuopio, Finland). Comparison of the acceptability of dry powder inhalers. A meta-analysis based on international data. Eur Respir J 2002; 20: Suppl. 38, 3138

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of acceptability, efficacy and safety of a novel dry powder inhaler in patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 Performance characteristics of a multi dose dry powder inhaler (MDPI) with respect to the use of different deaggregation systems Source: Eur Respir J 2004; 24: Suppl. 48, 582s Year: 2004 Impact of critical handling errors on delivered budesonide/formoterol dose in dry powder inhalers – An in vitro study Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 A study to evaluate the therapeutic equivalence of a new multidose budesonide dry powder inhaler with a conventional budesonide dry powder inhaler Source: Eur Respir J 2001; 18: Suppl. 33, 156s Year: 2001 Clinical equivalence of budesonide delivered via two dry powder inhalers Source: Eur Respir J 2005; 26: Suppl. 49, 339s Year: 2005 A novel, standardised questionnaire for assessing the determinants of the patient‘s preference for a dry powder inhaler (DPI): the validation of the handling questionnaire Source: Eur Respir J 2006; 28: Suppl. 50, 57s Year: 2006 Inhalation parameters from an integrated electronic multidose dry powder inhaler (eMDPI) Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 In vitro comparison of dose accuracy of two budesonide/formoterol dry powder inhalers Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001 In vitro testing of two budesonide dry powder inhalers at different flow rates Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001 Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Dose delivery characteristics of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 291s Year: 2004 In-use performance of sofotec´s dry powder inhaler Source: Eur Respir J 2004; 24: Suppl. 48, 584s Year: 2004 Once-daily budesonide: clinical equivalence of two dry powder inhalers (DPIs) Source: Eur Respir J 2005; 26: Suppl. 49, 339s Year: 2005 Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 121s Year: 2001 Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)? Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005 Acceptability of two dry powder inhalers in 645 asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005 Ease of use of inhalers and its impact on treatment adherence and control of asthma. An observational study Source: International Congress 2017 – Inhalers and their use Year: 2017 Dry powder inhalers in asthma and COPD. Which factors determine the frequency of handling errors? Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007